Treatment Patterns and Outcomes in Triple-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma: Findings From the Multinational ITEMISE Study.

MLA

Dhanasiri, Sujith, et al. “Treatment Patterns and Outcomes in Triple-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma: Findings From the Multinational ITEMISE Study.” Clinical Therapeutics, vol. 43, no. 11, Nov. 2021, p. 1983. EBSCOhost, https://doi.org/10.1016/j.clinthera.2021.09.013.

APA

Dhanasiri, S., Hollier-Hann, G., Stothard, C., Dhanda, D. S., Davies, F. E., & Rodriguez-Otero, P. (2021). Treatment Patterns and Outcomes in Triple-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma: Findings From the Multinational ITEMISE Study. Clinical Therapeutics, 43(11), 1983. https://doi.org/10.1016/j.clinthera.2021.09.013

Chicago

Dhanasiri, Sujith, Georgia Hollier-Hann, Catherine Stothard, Devender S Dhanda, Faith E Davies, and Paula Rodriguez-Otero. 2021. “Treatment Patterns and Outcomes in Triple-Class Exposed Patients With Relapsed and Refractory Multiple Myeloma: Findings From the Multinational ITEMISE Study.” Clinical Therapeutics 43 (11): 1983. doi:10.1016/j.clinthera.2021.09.013.